Literature DB >> 32064956

Prolactin attenuates global cerebral ischemic injury in rat model by conferring neuroprotection.

Bhawna Vermani1, Sumedha Mukherjee1, Gaurav Kumar1,2, Ranjana Patnaik1,2.   

Abstract

Primary Objective: Limited available therapeutics for ischemic stroke necessitate dire need of designing novel strategies for combating ischemic pathophysiological cascade among which neuroprotective strategies emerge as positive approaches. The neuropeptide prolactin is a pleiotropic hormone that affects various physiological conditions and reportedly combats neurotoxicity, neuronal stress and provides neuroprotection to hippocampal neurons in vitro.Research Design: The study explores the ability of prolactin in conferring neuroprotection in global cerebral ischemia in vivo and attempts to optimize the dose of prolactin which will be effective for the same.Methods and Procedure: Global cerebral ischemia was induced in male rats by bilateral common carotid occlusion (BCCAO) and different physiological and biochemical parameters were evaluated. Also, cerebral infarction and percentage of brain edema were measured.
Results: The results revealed that prolactin significantly reduces cerebral infarct, brain water content and restores the physiological conditions like blood pressure, heart rate and cerebral blood flow. Also, prolactin markedly reduces the increased levels of the neurotransmitters (ɣ-aminobutyric acid and glutamate), cerebral calcium and nitrate in different brain compartments of ischemic rats.
Conclusion: Prolactin is able to ameliorate ischemia-reperfusion injury in rat brain and might be a potent candidate for further neuro-therapeutics development.

Entities:  

Keywords:  BCCAO; Neuroprotection; cerebral ischemia; prolactin; stroke

Mesh:

Substances:

Year:  2020        PMID: 32064956     DOI: 10.1080/02699052.2020.1726466

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  2 in total

1.  High-Dose Vitamin C Prevents Secondary Brain Damage After Stroke via Epigenetic Reprogramming of Neuroprotective Genes.

Authors:  Kahlilia C Morris-Blanco; Anil K Chokkalla; TaeHee Kim; Saivenkateshkomal Bhatula; Mario J Bertogliat; Alexis B Gaillard; Raghu Vemuganti
Journal:  Transl Stroke Res       Date:  2022-03-20       Impact factor: 6.800

Review 2.  The brain as a source and a target of prolactin in mammals.

Authors:  Ana R Costa-Brito; Isabel Gonçalves; Cecília R A Santos
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.